GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Cyclically Adjusted Book per Share

HLS Therapeutics (TSX:HLS) Cyclically Adjusted Book per Share : C$6.04 (As of Mar. 2024)


View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

HLS Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was C$3.781. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$6.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, HLS Therapeutics's average Cyclically Adjusted Book Growth Rate was 5.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of HLS Therapeutics was 22.00% per year. The lowest was -5.30% per year. And the median was 5.30% per year.

As of today (2024-05-28), HLS Therapeutics's current stock price is C$3.70. HLS Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was C$6.04. HLS Therapeutics's Cyclically Adjusted PB Ratio of today is 0.61.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HLS Therapeutics was 6.48. The lowest was 0.58. And the median was 1.25.


HLS Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for HLS Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Cyclically Adjusted Book per Share Chart

HLS Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.74 4.29 4.96 5.60 5.96

HLS Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.73 5.85 5.94 5.96 6.04

Competitive Comparison of HLS Therapeutics's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLS Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HLS Therapeutics's Cyclically Adjusted PB Ratio falls into.



HLS Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HLS Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.781/126.2576*126.2576
=3.781

Current CPI (Mar. 2024) = 126.2576.

HLS Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.389 99.473 3.032
201409 2.452 99.394 3.115
201412 2.782 98.367 3.571
201503 2.703 99.789 3.420
201506 2.703 100.500 3.396
201509 2.673 100.421 3.361
201512 2.638 99.947 3.332
201603 2.697 101.054 3.370
201606 2.616 102.002 3.238
201609 2.608 101.765 3.236
201612 2.566 101.449 3.194
201703 2.568 102.634 3.159
201706 2.590 103.029 3.174
201709 2.478 103.345 3.027
201712 8.397 103.345 10.259
201803 8.945 105.004 10.756
201806 8.840 105.557 10.574
201809 7.968 105.636 9.523
201812 7.802 105.399 9.346
201903 7.689 106.979 9.075
201906 8.346 107.690 9.785
201909 8.121 107.611 9.528
201912 7.556 107.769 8.852
202003 7.395 107.927 8.651
202006 7.197 108.401 8.383
202009 7.037 108.164 8.214
202012 6.813 108.559 7.924
202103 6.614 110.298 7.571
202106 6.436 111.720 7.273
202109 6.436 112.905 7.197
202112 6.340 113.774 7.036
202203 6.201 117.646 6.655
202206 5.704 120.806 5.961
202209 5.410 120.648 5.662
202212 5.262 120.964 5.492
202303 5.029 122.702 5.175
202306 4.584 124.203 4.660
202309 4.284 125.230 4.319
202312 4.099 125.072 4.138
202403 3.781 126.258 3.781

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


HLS Therapeutics  (TSX:HLS) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

HLS Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.70/6.04
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of HLS Therapeutics was 6.48. The lowest was 0.58. And the median was 1.25.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


HLS Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HLS Therapeutics (TSX:HLS) Business Description

Industry
Traded in Other Exchanges
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.
Executives
Polar Asset Management Partners Inc. 10% Security Holder

HLS Therapeutics (TSX:HLS) Headlines

No Headlines